Brief: Nightingale Health Enters Partnership With Weavr Health

Nightingale Health Oyj

29/06/2021 07:43

June 29 (Reuters) - Nightingale Health Oyj  HEALTH.HE :
    * NIGHTINGALE SECURES GLOBAL SCALABILITY OF ITS AT-HOME
SOLUTION
BY PARTNERING WITH AT-HOME BLOOD COLLECTION DEVICE MANUFACTURER
WEAVR WITH NEW COMMERCIAL TERMS AND MINORITY INVESTMENT
    * EXPANDING EXISTING DISTRIBUTION AGREEMENT BETWEEN PARTIES
WITH
NEW COMMERCIAL TERMS
    * NEW COMMERCIAL TERMS ARE EFFECTIVE AS OF TODAY
    * CLOSED A MINORITY INVESTMENT TO WEAVR
    * PARTNERSHIP ENABLES GLOBAL SCALABILITY OF NIGHTINGALE'S
AT-HOME
TESTING SOLUTION
    * WILL LAUNCH COMMERCIAL AT-HOME TESTING OFFERING TO
CONSUMERS AND
ALSO TO BUSINESS PARTNERS IN FIRST HALF OF 2022
    * NIGHTINGALE INVESTED APPROXIMATELY 3.5 MILLION EUROS (4
MILLION
U.S. DOLLARS) TO WEAVR IN FORM OF A CONVERTIBLE LOAN
    * CONVERTIBLE LOAN SHALL BE CONVERTED INTO WEAVR'S PREFERRED
SHARES IN CONNECTION TO A SERIES C FINANCING ROUND

Source text for Eikon:  ID:nWkr82FJD4 
Further company coverage:  HEALTH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))